QTREX Quantum Ltd.
QTEX, QTEXW · Surgical & Medical Instruments & Apparatus · EDGAR filings ↗
Reference price $3.50 — last insider sale, 2026-06-01 (estimated from the dated SEC Form 4 price — not a live quote)
Grade
D41Pre-commercial respiratory-device micro-cap with deep losses, ~0% gross margin and a cash runway of only ~1.3 quarters.
Strengths
- Holds FDA marketing authorization for one product and has distribution agreements in place
- Current/quick ratios above 1 provide minimal near-term cover
Risks
- Cash runway 1.3 quarters (16.7th pct) on $3.2M cash with ~$13M annual loss — acute near-cash-out funding risk
- Bottom-decile margins (net -46%, operating -47%, gross 0.7%) and $80M accumulated deficit; no meaningful revenue
Notable findings
- Net lossNet loss (net margin -4574.4%)
- Cash burnNegative free cash flow (-10.0M)
- Insider sellingInsider selling — 7 open-market sale(s) by 2 insider(s) (cluster of 2 insiders, ~$398,980, last 6mo) Form 4 ↗
Key metrics
Gross margin
0.7%
Operating margin
-4713.8%
Net margin
-4574.4%
Return on equity
-569.1%
Return on assets
-247.5%
Current ratio
1.6×
Free cash flow
-$10M
Tangible book value
$2M
Cash & investments
$3M
Cash runway
1q
Stock comp / revenue
1237.0%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-01 | Tehila Yafit | Sell | 28K | $3.50 |
| 2026-05-29 | Yechezkely Hayon Daniella | Sell | 50K | $3.00 |
| 2026-05-29 | Tehila Yafit | Sell | 1.9K | $3.51 |
| 2026-05-29 | shabtay abraham | Option exercise | 95K | $3.37 |
| 2026-05-28 | Tehila Yafit | Sell | 15K | $3.00 |
| 2026-05-28 | Tehila Yafit | Sell | 15K | $2.56 |
| 2026-05-27 | Tehila Yafit | Sell | 16K | $2.01 |
| 2026-05-27 | Tehila Yafit | Option exercise | 14K | $0.12 |
| 2026-05-27 | Tehila Yafit | Sell | 14K | $2.03 |
All non-derivative Form 4 activity (SEC), newest first.
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 20-F | 2026-03-26 | 2025-12-31 | 0001185185-26-001072 ↗ |
| 20-F | 2025-03-10 | 2024-12-31 | 0001213900-25-022325 ↗ |
| 20-F | 2024-03-25 | 2023-12-31 | 0001213900-24-025316 ↗ |
| 20-F | 2023-03-31 | 2022-12-31 | 0001213900-23-025412 ↗ |
| 20-F | 2022-03-31 | 2021-12-31 | 0001213900-22-016867 ↗ |